Day: November 26, 2021

AnPac Bio Reports Nine Months Ended September 30, 2021, Same Period Achieved Record Revenue Increased By 55.3% While Non-GAAP Net Loss Reduced by 6.8%

AnPac Bio Reports Nine Months Ended September 30, 2021, Same Period Achieved Record Revenue Increased By 55.3% While Non-GAAP Net Loss Reduced by 6.8%

PHILADELPHIA, Nov. 26, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its unaudited financial results for the nine months ended September 30, 2021. The Company’s financial statements and related financial information for the quarter ended September 30, 2021 are unaudited and have not been reviewed by the Company’s independent registered accountant. These financial results could differ materially if they were reviewed by the Company’s independent registered accountant. Financial highlights: Total revenue was approximately RMB13.7 million (US$2.1 million) for the nine months ended September 30, 2021, an increase of 55.3% from RMB8.8 million for the same period of 2020. Gross...

Continue reading

<div>Theratechnologies Named Recipient of the 2021 ADRIQ Innovation Award in the "Life Sciences" Category</div>

Theratechnologies Named Recipient of the 2021 ADRIQ Innovation Award in the “Life Sciences” Category

MONTREAL, Nov. 26, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies, or Company) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, is pleased to announce that it was awarded of the 2021 Innovation Award in the “Life Sciences” category at the 31st ADRIQ Innovation Awards Gala held on November 25, 2021. Every year, the ADRIQ (Association pour le développement de la recherche et de l’innovation du Québec) gala rewards Quebec-based companies for leadership in innovation in their respective field. At the beginning of 2021, Theratechnologies received the United States Food and Drug Administration’s “Fast-track” designation for TH1902 as a single agent for the treatment of patients with advanced and recurrent solid tumors...

Continue reading

Sanoma Corporation – Acquisition of own shares on 26 November 2021

Sanoma Corporation – Acquisition of own shares on 26 November 2021

SANOMA CORPORATION, STOCK EXCHANGE RELEASE, 26 November 2021 at 19:00 EET Sanoma Corporation – Acquisition of own shares on 26 November 2021 At Nasdaq Helsinki Ltd: Date 26 November 2021 Exchange transaction Buy Share trading code SAA1V Amount, shares  13,000 Average price/share, EUR 13.589 Total cost, EUR 176,657.00 The company holds a total of 527,772 of its own shares (SAA1V) including the shares acquired on 26 November 2021. Detailed information concerning the acquisition is attached to this stock exchange release. On behalf of Sanoma Corporation DANSKE BANK A/S, FINLAND BRANCH Jonathan Nyberg        Antti Väliaho Additional information Kaisa Uurasmaa, Head of Investor Relations and Sustainability, tel. +358 40 560 5601 Sanoma Sanoma is an innovative and agile learning and media company impacting the lives of millions...

Continue reading

Fobi to Host Shareholder Update and Earnings Webinar

Fobi to Host Shareholder Update and Earnings Webinar

VANCOUVER, British Columbia, Nov. 26, 2021 (GLOBE NEWSWIRE) — Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the “Company” or “Fobi”), a leading data intelligence company using artificial intelligence to help clients turn real-time data into actionable insights and personalized customer engagement, is pleased to announce that Fobi will host a virtual-only shareholder update webinar on Thursday, December 2, 2021, from 9-10am PST (12-1pm EST). The shareholder update webinar will be facilitated by Rob Anson, CEO and Mark Lotz, CFO, who will review the company’s most recent reporting period as well as discuss milestones, financial strength, M&A and the outlook for the remainder of the fiscal year. Fobi CEO Rob Anson and CFO Mark Lotz will facilitate pre-submitted and live-chat questions and answers. The company will answer pre-submitted...

Continue reading

ABO-Group Environment announces the appointment of their new CFO Floris Pelgrims

ABO-Group Environment announces the appointment of their new CFO Floris Pelgrims

Ghent, 26th of November 2021, 17:45 – Press release / Regulatory Information As of 1 January 2022, Floris Pelgrims will start as the new Chief Financial Officer (CFO) and Compliance Officer for ABO-Group Environment. Floris holds two master’s degrees, one in commercial engineering and one in financial management from the universities of KU Leuven and Vlerick Management School. The 40-year-old Floris has experience in various sectors and companies, most recently as financial director at BESIX Stay. Frank De Palmenaer, CEO of ABO-Group, declares: “Floris offers strong added value to support and strengthen the group’s growth ambition. He is a young and dynamic person who will be able to oversee the financial integration and the alignment of the newcomers within the group”. The Board of Directors is confident that Floris will make...

Continue reading

Dékuple: 2021 NINE-MONTH NET SALES: €117.1M (+18.2%)

Dékuple: 2021 NINE-MONTH NET SALES: €117.1M (+18.2%)

2021 NINE-MONTH NET SALES: €117.1M (+18.2%) THIRD-QUARTER GROWTH OF +21.5% DIGITAL MARKETING UP +46% OVER NINE MONTHS Paris, 26 November 2021 (5:45pm) – The DÉKUPLE Group, a cross-channel data marketing expert, is reporting its revenues for the first nine months of 2021. Bertrand Laurioz, Chairman and CEO: “DÉKUPLE maintained its excellent performance during the first nine months of the year. Net sales at end-September are up 18.2% year-on-year, with all of our business lines contributing to this strong growth. The Digital Marketing business achieved 46% growth, representing 43.3% of net sales at end-September 2021, compared with 35% at end-September 2020. The Group has continued to build on its strong organic growth in the Consulting business, while benefiting from its extended operational scope for Marketing Engineering following...

Continue reading

KBC Ancora to distribute an interim dividend of EUR 2.30 per share on 9 December 2021

KBC Ancora to distribute an interim dividend of EUR 2.30 per share on 9 December 2021

Regulated information, inside information, Leuven, 26 November 2021 (17.40 hrs CET)   KBC Ancora to distribute an interim dividend of EUR 2.30 per share on 9 December 2021   One-off deviation from KBC Ancora’s usual dividend calendar in the light of the additional dividend paid by KBC Group on 17 November 2021 in respect of the 2020 financial year   The Board of Directors of Almancora Société de gestion, statutory director of KBC Ancora, decided at its meeting on 26 November 2021 to declare an interim dividend of EUR 2.30 gross per KBC Ancora share, payable on 9 December 2021. The net coupon amount after deduction of 30% withholding tax amounts to EUR 1.61 per share.   In normal circumstances, KBC Ancora pays its dividend in the form of an interim dividend in June of the financial year concerned. The decision to distribute an interim...

Continue reading

Suominen Corporation: SHARE REPURCHASE 26.11.2021

Suominen Corporation: SHARE REPURCHASE 26.11.2021

Suominen Corporation ANNOUNCEMENT 26.11.2021             Suominen Corporation: SHARE REPURCHASE 26.11.2021       In the Helsinki Stock Exchange           Trade date 26.11.2021   Bourse trade Buy   Share SUY1V   Amount 9,000 Shares Average price/ share 4.7953 EUR Total cost 43,157.70 EUR             Suominen Corporation now holds a total of 787 561 shares including the shares repurchased on 26.11.2021             On behalf of Suominen Corporation         Nordea Bank Oyj           Janne Sarvikivi Sami Huttunen         For additional information, please contact:   Toni Tamminen, CFO, Suominen Corporation   tel. +358 (0)10 214 3051           www.suominen.fi     Attachment Suominen 26.11 trades

Continue reading

Psyence Group Invited as First Psychedelic Company to present at the 15th-Annual Global Wellness Summit

Psyence Group Invited as First Psychedelic Company to present at the 15th-Annual Global Wellness Summit

TORONTO, Nov. 26, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology company with a focus on natural psychedelics in mental health and well-being, will break new ground as the first psychedelic company invited to speak at the 15th Annual Global Wellness Summit, a gathering of international leaders in the $4.5 trillion global wellness economy.1 Meeting in Boston November 30 to December 3, 2021, the summit includes doctors, activists, and health care executives from research organizations that include Harvard, Massachusetts Institute of Technology (MIT), Cleveland Clinic and elsewhere. Psyence’s Head of Corporate Social Responsibility, Mary-Elizabeth Gifford, will host an in-person keynote conversation with Rick Doblin, PhD, Founder and Executive Director...

Continue reading

Nordic American Tankers Ltd (NYSE: NAT) – Purchase of shares by NAT board member Alexander Hansson (DUPLICATE)

Nordic American Tankers Ltd (NYSE: NAT) – Purchase of shares by NAT board member Alexander Hansson (DUPLICATE)

Friday, November 26, 2021 Dear Shareholders and Investors,  Alexander Hansson, Board member in Nordic American Tankers Ltd and son of Herbjorn Hansson, the NAT Founder, Chairman and CEO, has today bought 50,000 share in NAT at $1.8564  per share. Following the transaction, Alexander Hansson privately owns 1,035,000 shares in Nordic American Tankers Ltd.  As in the past, the Hansson family is the largest private shareholder in NAT. Alexander Hansson commented: “Uncertain times are normally good for our tankers. The recent set-back in stock markets is a good opportunity to accumulate shares” Sincerely, Herbjorn Hansson  Founder, Chairman & CEO  Nordic American Tankers Ltd.                                                           www.nat.bm   CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Matters discussed in this press...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.